Research ArticleAutoimmunity

Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes

See allHide authors and affiliations

Science Translational Medicine  09 Aug 2017:
Vol. 9, Issue 402, eaaf7779
DOI: 10.1126/scitranslmed.aaf7779

Log in to view full text


Navigate This Article